These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1699471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR.
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The neurochemistry of Alzheimer's disease.
    Engelborghs S, De Deyn PP.
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [Abstract] [Full Text] [Related]

  • 7. [Neuromodulators and Alzheimer's disease].
    Vallet PG, Bouras C.
    Encephale; 1988 Jun; 14(5):345-51. PubMed ID: 2463900
    [Abstract] [Full Text] [Related]

  • 8. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF, Clevens RA, Chattha GK, MacGarvey UM, Mazurek MF, Gabriel SM.
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [Abstract] [Full Text] [Related]

  • 9. Galanin mRNA in the nucleus basalis of Meynert complex of baboons and humans.
    Walker LC, Rance NE, Price DL, Young WS.
    J Comp Neurol; 1991 Jan 01; 303(1):113-20. PubMed ID: 1706362
    [Abstract] [Full Text] [Related]

  • 10. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ.
    Adv Neurol; 1987 Jan 01; 45():393-7. PubMed ID: 2881448
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ, Flatz WH, Heinsen H, Bokde AL, Schoenberg SO, Stöckel S, Dietrich O, Reiser MF, Möller HJ, Hampel H.
    Brain; 2005 Nov 01; 128(Pt 11):2626-44. PubMed ID: 16014654
    [Abstract] [Full Text] [Related]

  • 12. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H, Iizuka R.
    Nihon Rinsho; 1988 Jul 01; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F, Faucheux B, Ruberg M, Agid Y, Hirsch EC.
    Exp Neurol; 1997 May 01; 145(1):245-52. PubMed ID: 9184126
    [Abstract] [Full Text] [Related]

  • 15. Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey.
    Walker LC, Koliatsos VE, Kitt CA, Richardson RT, Rökaeus A, Price DL.
    J Comp Neurol; 1989 Feb 08; 280(2):272-82. PubMed ID: 2466877
    [Abstract] [Full Text] [Related]

  • 16. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C.
    Exp Neurol; 2005 Oct 08; 195(2):484-96. PubMed ID: 16085017
    [Abstract] [Full Text] [Related]

  • 17. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.
    Chan-Palay V.
    Adv Neurol; 1990 Oct 08; 51():253-5. PubMed ID: 1688477
    [No Abstract] [Full Text] [Related]

  • 18. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
    Kowall NW, Beal MF.
    Neurosci Lett; 1989 Mar 13; 98(1):118-23. PubMed ID: 2469045
    [Abstract] [Full Text] [Related]

  • 19. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
    López OL, DeKosky ST.
    Rev Neurol; 1989 Mar 13; 37(2):155-63. PubMed ID: 12938076
    [Abstract] [Full Text] [Related]

  • 20. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
    Sparks DL, Markesbery WR, Slevin JT.
    Ann Neurol; 1986 Jun 13; 19(6):602-4. PubMed ID: 2425718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.